Assignee
SAMJIN PHARM CO LTD
KR·15 granted patents·6 pending applications·70 citations·filing 1993–2023
Top patents by PatentIndex Score
21 records- 0177US6987114B1Antiviral pyrimidinedione derivatives and process for the preparation thereofSAMJIN PHARM CO LTD·Filed 2000·Granted Jan 17, 2006·9 cites·5 claims
- 0273US6683184B2Piperazine derivatives and process for the preparation thereofSAMJIN PHARM CO LTD·Filed 2002·Granted Jan 27, 2004·6 cites·3 claims
- 0372US6028195APiperazine derivatives and process for the preparation thereofSAMJIN PHARM CO LTD·Filed 1997·Granted Feb 22, 2000·35 cites·3 claims
- 0469US7851479B2Use of pyrimidinedione derivative for preventing or treating hepatitis CSAMJIN PHARM CO LTD·Filed 2007·Granted Dec 14, 2010·1 cites·3 claims
- 0567US11420963B2Rebamipide prodrugs, preparation method and use thereofSAMJIN PHARM CO LTD·Filed 2013·Granted Aug 23, 2022·1 cites·12 claims
- 0666US5922727AAntiviral substituted pyrimidinedione homocarbocyclic nucleoside derivatives and methods for the preparation thereof and compositions containing the same as active ingredientsSAMJIN PHARM CO LTD·Filed 1996·Granted Jul 13, 1999·13 cites·3 claims
- 0761US2025171451A1Novel heterocyclic compound and pharmaceutical composition comprising sameSAMJIN PHARM CO LTD·Filed 2023·Application pending·0 cites
- 0857US11712414B2Oral pharmaceutical composition for preventing or treating dry eye syndrome comprising rebamipide or a prodrug thereofSAMJIN PHARM CO LTD·Filed 2014·Granted Aug 1, 2023·0 cites·11 claims
- 0957US2025281472A1Ophthalmic composition inhibiting occurrence of n-oxopyridine compound for preventing or treating eye diseaseSAMJIN PHARM CO LTD·Filed 2022·Application pending·0 cites
- 1051US10918725B2Ophthalmic composition comprising rebamipide and method for preparing the sameSAMJIN PHARM CO LTD·Filed 2016·Granted Feb 16, 2021·0 cites·7 claims
- 1149US12590070B2Adamantane derivatives as inhibitors of focal adhesion kinaseSAMJIN PHARM CO LTD·Filed 2020·Granted Mar 31, 2026·0 cites·17 claims
- 1249US2023025836A1Eye drop composition for preventing or treating eye diseaseSAMJIN PHARM CO LTD·Filed 2020·Application pending·0 cites
- 1346US6274732B1Process for the preparation of 1-[(cyclopent-3-en-1-yl)-methyl]-5-ethyl-6-(3,5-dimethylbenzoyl)-2,4-pyrimidinedioneSAMJIN PHARM CO LTD·Filed 1999·Granted Aug 14, 2001·3 cites·8 claims
- 1446US2021393642A1Composition for preventing or treating sjogren's syndromeSAMJIN PHARM CO LTD·Filed 2019·Application pending·0 cites
- 1546US2022218685A1Composition for treating eye diseasesSAMJIN PHARM CO LTD·Filed 2020·Application pending·0 cites
- 1641US10844062B2Pyridine derivative inhibiting RAF kinase and vascular endothelial growth factor receptor, method for preparing same, pharmaceutical composition containing same, and use thereofSAMJIN PHARM CO LTD·Filed 2017·Granted Nov 24, 2020·0 cites·7 claims
- 1741US7230105B29-aminoacridine derivatives and process for the preparation thereofSAMJIN PHARM CO LTD·Filed 2002·Granted Jun 12, 2007·0 cites·3 claims
- 1839US10301291B2Imidazole derivative having JNK inhibitory activity and use thereofSAMJIN PHARM CO LTD·Filed 2017·Granted May 28, 2019·0 cites·13 claims
- 1937US6620936B29-aminoacridine derivatives and process for the preparation thereofSAMJIN PHARM CO LTD·Filed 2001·Granted Sep 16, 2003·0 cites·4 claims
- 2037US5747521AN-cinnamoyl-2-methyl-5-methoxy-3-indoleacetic acid ester, and pharmaceutical preparation containing the sameSAMJIN PHARM CO LTD·Filed 1993·Granted May 5, 1998·2 cites·2 claims
- 2134US2019038564A1Carvedilol Immediate Release Formulation Having Improved MadescentSAMJIN PHARM CO LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SAMJIN PHARM CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →